EsoBiotec
EsoBiotec is a vivo engineered cell therapies for cancer treatment founded in 2020.
1
Funding Rounds
$2.2m
Money raised
Overview
EsoBiotec is a vivo engineered cell therapies for cancer treatment founded in 2020.
- Website:
- Business model: B2C
- Headquarters: Brussels
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company EsoBiotec has raised a total of $2.2m in funding over 1 rounds.
Key Insights:
- EsoBiotec December 2023 Series A Funding Round: $2.2m
EsoBiotec December 2023 Series A Funding Round
$2.2m